These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6185638)

  • 21. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB; Creese I; Snyder SH
    J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497
    [No Abstract]   [Full Text] [Related]  

  • 22. Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine.
    Nielsen EB; Nielsen M; Ellison G; Braestrup C
    Eur J Pharmacol; 1980 Aug; 66(2-3):149-54. PubMed ID: 7439269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The residual effect of chronic neuroleptic treatment on the neuroleptic binding assay in rats.
    Wan CW; Peck EJ; Ho BT; Schoolar JC
    Life Sci; 1983 Mar; 32(11):1255-62. PubMed ID: 6834989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.
    Arnett CD; Fowler JS; Wolf AP; Shiue CY; McPherson DW
    Life Sci; 1985 Apr; 36(14):1359-66. PubMed ID: 3872397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of specific in vivo labeling of neuroleptic binding sites with 3-N-[11C]methylspiperone.
    Yanai K; Ido T; Ishiwata K; Hatazawa J; Watanuki S; Takahashi T; Ujiie A; Ito M; Matsuzawa T
    Eur J Nucl Med; 1986; 11(11):438-43. PubMed ID: 3486764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2.
    Hatano K; Ishiwata K; Kawashima K; Hatazawa J; Itoh M; Ido T
    J Nucl Med; 1989 Apr; 30(4):515-22. PubMed ID: 2567779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (3H) spiroperidol binding decreases in brains of rats infected with Venezuelan equine encephalomyelitis virus.
    Bonilla E; Salazar M; Estevez J; Hernández H; Rangel P
    Experientia; 1984 Aug; 40(8):868-9. PubMed ID: 6468605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between centrifugation and filtration as a means to separate bound and unbound ligand during 3[H]-spiroperidol binding.
    Csernansky CA; Csernansky JG; Hollister LE
    J Pharmacol Methods; 1985 Jun; 13(3):187-91. PubMed ID: 3999754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors.
    Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M
    Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic drug-induced dopamine receptor supersensitivity: antagonism by L-prolyl-L-leucyl-glycinamide.
    Chiu S; Paulose CS; Mishra RK
    Science; 1981 Dec; 214(4526):1261-2. PubMed ID: 6117947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats.
    Bhargava HN
    Eur J Pharmacol; 1984 Apr; 100(1):109-12. PubMed ID: 6723774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary.
    Serri O; Renier G; Somma M
    Horm Res; 1985; 21(2):95-101. PubMed ID: 3979949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 38. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W; Peinhardt G; Büge A
    Pharmazie; 1985 May; 40(5):341-2. PubMed ID: 2863832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic and dopamine receptors: autoradiographic localization of [3H]spiperone in rat brain.
    Klemm N; Murrin LC; Kuhar MJ
    Brain Res; 1979 Jun; 169(1):1-9. PubMed ID: 455088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.